|Over a week ago|
Arkema price target raised to EUR 95 from EUR 90 at Credit Suisse » 12:1006/1906/19/20
Credit Suisse analyst…
Credit Suisse analyst Chris Counihan raised the firm's price target on Arkema to EUR 95 from EUR 90 and keeps an Outperform rating on the shares.
|Over a month ago|
Arkema price target raised to EUR 80 from EUR 74 at UBS » 12:1306/0106/01/20
UBS analyst Geoff Haire…
UBS analyst Geoff Haire raised the firm's price target on Arkema to EUR 80 from EUR 74 and keeps a Neutral rating on the shares.
|Over a quarter ago|
Arkema price target lowered to EUR 89 from EUR 107 at Morgan Stanley » 13:1703/3003/30/20
Morgan Stanley analyst…
Morgan Stanley analyst Alexandra Thrum lowered the firm's price target on Arkema to EUR 89 from EUR 107 and keeps an Overweight rating on the shares.
Arkema price target lowered to EUR 78 from EUR 110 at JPMorgan » 12:1903/2403/24/20
JPMorgan analyst Chetan…
JPMorgan analyst Chetan Udeshi lowered the firm's price target on Arkema to EUR 78 from EUR 110 and keeps an Overweight rating on the shares.
Arkema double-upgraded to Buy from Sell at Goldman Sachs » 17:3803/0403/04/20
Goldman Sachs analyst…
Goldman Sachs analyst Georgina Iwamoto double-upgraded Arkema to Buy from Sell with a price target of EUR 101, up from EUR 85. The analyst notes that the stock has underperformed the broader market by 18% since November 2018 due to a cyclical downturn in the commodity segments, lack of clarity on capital allocation, and investor hesitation to buy a complex and subs-scale portfolio. Iwamoto adds that while she remains cautious on the commodities, she sees the risk for Arkema having been priced in, turning more constructive on the potential for specialty earnings growth to offset cyclical weakness. The analyst further states that the company's Capital Markets Day could offer a catalyst with more updates and clarity on its M&A strategy and capital allocation policy.
Arkema upgraded to Overweight from Neutral at JPMorgan » 21:3002/2502/25/20
JPMorgan analyst Chetan…
JPMorgan analyst Chetan Udeshi upgraded Arkema to Overweight from Neutral with a EUR 110 price target. The analyst believes the presence of an activist serves as a potential catalyst to unlock shareholder value.
Arkema upgraded to Hold from Reduce at Kepler Cheuvreux » 05:4102/0402/04/20
Kepler Cheuvreux analyst…
Kepler Cheuvreux analyst Martin Roediger upgraded Arkema to Hold from Reduce with an EUR 85 price target.
Arkema downgraded to Equal Weight from Overweight at Barclays » 05:3801/1601/16/20
Barclays analyst Alex…
Barclays analyst Alex Stewart downgraded Arkema to Equal Weight from Overweight with a EUR 105 price target. The stock has rallied from last summer's trough "but faces another challenging year," Stewart tells investors in a research note. The analyst sees risk to EBITDA consensus estimates this year, and feels capex forecasts look too low.
Credit Suisse to hold a conference » 08:5212/0312/03/19
AKZOY, ARKAY, BASFY, COVTY, COIHY, EMNSF, FUPBY, NVZMY, SOLVY, YARIY
2019 Specialty Chemicals…
2019 Specialty Chemicals Conference will be held in London, England on December 3.
Arkema management to meet with Morgan Stanley » 04:5509/0409/04/19
Meeting to be held in New…
Meeting to be held in New York on September 4 hosted by Morgan Stanley.